Q3 2023 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2023-11-14 · accession 0001172661-23-004050
$105.9M
Reported value
7
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $35.3M | 33.3% | 797,436 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $21.8M | 20.6% | 4,697,785 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $20.0M | 18.9% | 676,047 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $13.0M | 12.2% | 2,377,665 | Common | SOLE |
| 63009R109 | NSTGEUR | NANOSTRING TECHNOLOGIES INC | $6.5M | 6.09% | 3,751,891 | Common | SOLE |
| 57777K106 | MXCT | MAXCYTE INC | $5.9M | 5.55% | 1,885,000 | Common | SOLE |
| 835431107 | — | SONENDO INC | $3.5M | 3.27% | 4,643,461 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.